DYURAL

Dyural is a biotechnology company focused on developing long-acting local anesthetics and pain management therapies. The company utilizes its proprietary DYURAL technology, a hydrogel-based drug delivery platform, to provide sustained release of established analgesic agents. Their lead programs aim to address the limitations of current post-operative pain treatments by extending the duration of pain relief from hours to several days. By providing a localized, non-opioid alternative for pain management, Dyural seeks to improve patient recovery outcomes and reduce the reliance on systemic opioids. The company's pipeline includes formulations targeting both surgical site pain and chronic conditions like osteoarthritis.